NEW YORK (GenomeWeb) – Researchers have uncovered somatic recombination events in the APP gene in both people with and without Alzheimer's disease, some of which might give rise to variants that contribute to the disease.

The process appears to rely on reverse transcriptase, suggesting HIV antiretroviral drugs that block this enzyme as a potential new treatment for Alzheimer's.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.